Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Microcirculation. 2018 Jan;25(1):10.1111/micc.12431. doi: 10.1111/micc.12431

Figure 5. Role of KV channels in forskolin-induced dilation of human coronary arterioles from non-CAD and CAD subjects.

Figure 5

The adenylate cyclase activator forskolin-induced dilation was markedly reduced in CAD arterioles as compared with non-CAD arterioles (A). The dilation was reduced by the general KV1 channel blocker 4-AP (5 × 10−3 M) in non-CAD (B) and to a lesser extent in CAD (C) arterioles. *P<0.05 versus non-CAD or control; n=4–8 vessels/group.